André Pannatier

Publications | Mémoires et thèses

La recherche avancée est accessible via Serval

Les publications peuvent être gérées en accédant à Serval via MyUnil


74 publications

Sous presse | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1993 | 1992 | 1990 | 1988 | 1986 |
 
Inhalation technique practical skills and knowledge among physicians and nurses in two pediatric emergency settings.
Spaggiari S., Gehri M., Di Benedetto L., Hafen G.M., Pauchard J.Y., Gervaix A., Pannatier A., Sadeghipour F., Di Paolo E.R. Journal of Asthma pp. 1-9. Peer-reviewed.
 
Incident reports versus direct observation to identify medication errors and risk factors in hospitalised newborns.
Palmero D., Di Paolo E.R., Stadelmann C., Pannatier A., Sadeghipour F., Tolsa J.F., 2019/02. European Journal of Pediatrics, 178 (2) pp. 259-266. Peer-reviewed.
 
Reply to Sorooshian and Snow, "Is Alternate-Day Therapeutic Drug Monitoring in the Intensive Care Unit Not Intensive Enough?"
Fournier A., Eggimann P., Pantet O., Pagani J.L., Dupuis-Lozeron E., Pannatier A., Sadeghipour F., Voirol P., Que Y.A., 2018/10. Antimicrobial agents and chemotherapy, 62 (10). Peer-reviewed.
 
Stability of prostaglandin E1 solutions stored in polypropylene syringes for continuous intravenous administration to newborns
Palmero D., Chavan E., Berger-Gryllaki M., Tolsa J.F., Di Paolo E.R., Pannatier A., Henry H., Sadeghipour F., 2018. European Journal of Hospital Pharmacy, 25 pp. e109-114.
 
Pharmacist intervention acceptance for the reduction of potentially inappropriate drug prescribing in acute psychiatry.
Hannou S., Voirol P., Pannatier A., Weibel M.L., Sadeghipour F., von Gunten A., Mall J.F., De Giorgi Salamun I., 2017/12. International journal of clinical pharmacy, 39 (6) pp. 1228-1236. Peer-reviewed.
 
Does the type of parenteral lipids matter? A clinical hint in critical illness.
Devaud J.C., Berger M.M., Pannatier A., Sadeghipour F., Voirol P., 2017/04. Clinical nutrition, 36 (2) pp. 491-496. Peer-reviewed.
 
Antibiotic consumption to detect epidemics of Pseudomonas aeruginosa in a burn centre: A paradigm shift in the epidemiological surveillance of Pseudomonas aeruginosa nosocomial infections.
Fournier A., Voirol P., Krähenbühl M., Bonnemain C.L., Fournier C., Pantet O., Pagani J.L., Revelly J.P., Dupuis-Lozeron E., Sadeghipour F. et al., 2016/05. Burns : journal of the International Society for Burn Injuries, 42 (3) pp. 564-570. Peer-reviewed.
 
A bundle with a preformatted medical order sheet and an introductory course to reduce prescription errors in neonates.
Palmero D., Di Paolo E.R., Beauport L., Pannatier A., Tolsa J.F., 2016. European Journal of Pediatrics, 175 (1) pp. 113-119. Peer-reviewed.
 
Antibiotics' consumption to early detect epidemics of P. aeruginosa in a burn center: a paradigm shift in the epidemiological surveillance of nosocomial infections
Fournier A, Eggimann P, Pantet O, Krähenbühl M, Bonnemain C-L, Fournier C, Pagani J-L, Revelly J-P, Dupuis-Lozeron E, Sadeghipour F et al., 2015. pp. P232 dans 3rd International Conference on Prevention and Infection Control (ICPIC 2015), Antimicrobial Resistance and Infection Control. Peer-reviewed.
 
Effective Treatment of Invasive Aspergillus fumigatus Infection Using Combinations of Topical and Systemic Antifungals in a Severely Burned Patient.
Fournier A., Pantet O., Guerid S., Eggimann P., Pagani J.L., Revelly J.P., Hauser P.M., Marchetti O., Fontanella S., Letovanec I. et al., 2015. Journal of Burn Care and Research, 36 (2) pp. e85-e89. Peer-reviewed.
 
Efficacy and safety of high-dose daptomycin (>6mg/kg) for complicated bone and joint infections and implant-associated infections caused by Gram-positive bacteria.
Perrottet N., Steinrücken J., Chan M., Pannatier A., Borens O., Yusuf E., Trampuz A., 2015. International Journal of Antimicrobial Agents, 46 (4) pp. 480-482. Peer-reviewed.
 
Impact of the introduction of real-time therapeutic drug monitoring on empirical doses of carbapenems in critically ill burn patients.
Fournier A., Eggimann P., Pagani J.L., Revelly J.P., Decosterd L.A., Marchetti O., Pannatier A., Voirol P., Que Y.A., 2015. Burns, 41 (5) pp. 956-968. Peer-reviewed.
 
Physicochemical aspects and efficiency of albuterol nebulization: comparison of three aerosol types in an in vitro pediatric model.
Sidler-Moix A.L., Di Paolo E.R., Dolci U., Berger-Gryllaki M., Cotting J., Pannatier A., 2015. Respiratory Care, 60 (1) pp. 38-46.
Stop using the flotation technique and start weighing salbutamol pressurised metered-dose inhalers without dose counters.
Di Paolo E.R., Spaggiari S., Pannatier A., Sadeghipour F., Rochat I., Hafen G.M., 2015. Swiss Medical Weekly, 145 pp. w14162. Peer-reviewed.
 
Aérosol-doseurs : un casse tête dans la détermination du contenu
Martignoni S., Hafen G., Pannatier A., Di Paolo E.R., 2014. PharmaJournal 10 pp. 5-6.
 
Albuterol delivery in an in vitro pediatric ventilator lung model: comparison of jet, ultrasonic, and mesh nebulizers.
Sidler-Moix A.L., Dolci U., Berger-Gryllaki M., Pannatier A., Cotting J., Di Paolo E.R., 2013. Pediatric Critical Care Medicine, 14 (2) pp. e98.
 
Aérosol-doseurs : un casse tête dans la détermination du contenu.
Martignoni S., Hafen G, Pannatier A, Di Paolo E.R., 2013. Paediatrica, 24 (5) pp. 48-50.
 
Evolving Trends in the Costs Associated With Hospital Use of Immunosuppressive Drugs.
Perrottet N., Aubert V., Venetz J.P., Ugolini E., Matter M., Pannatier A., Pascual M., 2013. Transplantation, 95 (5) pp. e24-e25.
 
Impact of Antibiotic Use on Carbapenem Resistance in Pseudomonas aeruginosa: Is There a Role for Antibiotic Diversity?
Plüss-Suard C., Pannatier A., Kronenberg A., Mühlemann K., Zanetti G., 2013. Antimicrobial Agents and Chemotherapy, 57 (4) pp. 1709-1713.
 
Stress ulcer prophylaxis in non-critically ill patients: a prospective evaluation of current practice in a general surgery department.
Bez C., Perrottet N., Zingg T., Leung Ki E.L., Demartines N., Pannatier A., 2013. Journal of Evaluation in Clinical Practice, 19 (2) pp. 374-378.
 
A highly sensitive LC-tandem MS assay for the measurement in plasma and in urine of salbutamol administered by nebulization during mechanical ventilation in healthy volunteers.
Sidler-Moix A.L., Mercier T., Decosterd L.A., Di Paolo E.R., Berger-Gryllaki M., Cotting J., Pannatier A., 2012. Biomedical Chromatography : BMC, 26 (5) pp. 672-680. Peer-reviewed.
 
Changes in the use of broad-spectrum antibiotics after cefepime shortage: a time series analysis.
Plüss-Suard Catherine, Pannatier André, Ruffieux Christiane, Kronenberg Andreas, Mühlemann Katrin, Zanetti Giorgio, 2012. Antimicrobial Agents and Chemotherapy, 56 (2) pp. 989-994. Peer-reviewed.
Drug utilisation in a neonatal intensive care unit of a swiss university hospital
Palmero D., Di Paolo E.R., Tolsa J.F., Pannatier A., 2012. p. 209 dans 40th International Symposium on Clinical Pharmacy (ESCP), Clinical Pharmacy: Connecting Care and Outcomes, International Journal of Clinical Pharmacy.
 
Five-year evolution of drug prescribing in a university adult intensive care unit.
Carron C., Voirol P., Eggimann P., Pannatier A., Chioléro R., Wasserfallen J.B., 2012. Applied Health Economics and Health Policy, 10 (5) pp. 355-358. Peer-reviewed.
 
Hypertriglyceridemia: a potential side effect of propofol sedation in critical illness.
Devaud J.C., Berger M.M., Pannatier A., Marques-Vidal P., Tappy L., Rodondi N., Chiolero R., Voirol P., 2012. Intensive Care Medicine, 38 (12) pp. 1990-1998. Peer-reviewed.
 
In vitro compatibility of remifentanil hydrochloride and sufentanil citrate with selected drugs
Humbert-Delaloye V., Berger M., Voirol P., Pannatier A., 2012. European Journal of Hospital Pharmacy-Science and Practice, 19 (1) pp. 57-64.
Outpatient prescription writing quality in a paediatric general hospital
Di Paolo E.R., Ruchet L., Gehri M., Lutz N., Fanconi S., Pannatier A., 2012. p. 249 dans 40th International Symposium on Clinical Pharmacy (ESCP), Clinical Pharmacy: Connecting Care and Outcomes, International Journal of Clinical Pharmacy.
Outpatient prescriptions practice and writing quality in a paediatric university hospital.
Di Paolo E., Gehri M., Ouedraogo-Ruchet L., Sibailly G., Lutz N., Pannatier A., 2012. Swiss Medical Weekly, 142 p. 0.
Quels sont les dangers liés à l'utilisation de suppositoires à base d'huiles essentielleschez les petits enfants?
Pellaud N., Hafen G., Di Paolo E.R., Pannatier A., 2012. Paediatrica, 23 (4) pp. 35-36.
 
Quels sont les dangers liés à l’utilisation de suppositoires à base d’huiles essentielles chez les petits enfants?
Di Paolo E.R., Pannatier A., 2012. Paediatrica, 23 (4) p. 35.
 
The hospital pharmacist: an important contributor to improved patient safety in the hospital.
Berthouzoz S., Berger L., Bonnabry P., Pannatier A., 2012. Chimia, 66 (5) pp. 300-303.
Traitement et prophylaxie de la Maladie ThromboEmbolique Veineuse (MTEV)
Centre hospitalier universitaire vaudois, Policlinique médicale universitaire (Lausanne) , 2011/05. 2 p..
 
Hospital antibiotic consumption in Switzerland: comparison of a multicultural country with Europe.
Plüss-Suard C., Pannatier A., Kronenberg A., Mühlemann K., Zanetti G., 2011. Journal of Hospital Infection, 79 (2) pp. 166-171.
 
Medicines manufacturing in hospital: from empirical craftsmanship to risk management
Pannatier A., 2011. EJHP Practice, 17 (1) p. 12.
 
Stress ulcer prophylaxis in non-critically ill patients: a prospective evaluation of current practice in a general surgery department
Zingg T., Bez C., Perrottet N., Leung Ki E.L., Pannatier A., Demartines N., 2011. p. 7 dans 98th Annual Congress of the Swiss Society of Surgery, British Journal of Surgery. Peer-reviewed.
 
Stress ulcer prophylaxis in non-critically ill patients: a prospective evaluation of the practice in a surgical ward
Perrottet N., Bez C., Zingg T., Leung Ki E.L., Demartines N., Pannatier A., 2011. p. 435 dans 39th ESCP (European Society of Clinical Pharmacy) European Symposium on Clinical Pharmacy and 13th SFPC (Société Française de Pharmacie Clinique) Congress: Clinical Pharmacy at the Front line of Innovations, International Journal of Clinical Pharmacy.
 
Substance P-induced skin inflammation is not modulated by a single dose of sitagliptin in human volunteers.
Grouzmann E., Bigliardi P., Appenzeller M., Pannatier A., Buclin T., 2011. Biological Chemistry, 392 (3) pp. 217-221.
Recombinant factor VIIa for intractable life-threatening bleeding in patients with circulatory assist devices.
Schneider A.G., Perez M.H., Tozzi P., Voirol P., Schoettker P., Angelillo-Scherrer A., Cotting J., Von Segesser L., Eggimann P., 2010/09. Intensive care medicine, 36 (9) pp. 1620-1621. Peer-reviewed.
 
Changes in the use of broad-spectrum antibiotics after withdrawal of cefepime from the market: an interrupted time series analysis
Pluess-Suard Catherine, Pannatier Andre, Zanetti Giorgio, 2010. p. 274 dans ESCP-GSASA 38th symposium on clinical pharmacy 30 years of clinical pharmacy, a bright future ahead, Pharmacy World and Science. Peer-reviewed.
 
Concomitant administration of intravenous drugs in the ICU: evaluation of physico-chemical compatibilities
Humbert-Delaloye V., Voirol P., Gattlen L., Berger L., Pannatier A., 2010. pp. 224-225 dans ESCP-GSASA 38th symposium on clinical pharmacy 30 years of clinical pharmacy; a bright future ahead., Pharmacy World and Science. Peer-reviewed.
 
Evaluation of the inhalation technique in asthmatic children visiting a specialised outpatient clinic
Breguet C., Di Paolo Ermindo R., Verga J., Gehri M., Pannatier A., 2010. p. 303 dans ESCP-GSASA 38th symposium on clinical pharmacy 30 years of clinical pharmacy, a bright future ahead, Pharmacy World and Science. Peer-reviewed.
 
Five-year evolution of drug prescribing in a university adult intensive care unit
Voirol P., Eggimann P., Carron C., Pannatier A., Chiolero R., Wasserfallen J.B., 2010. pp. P473 dans 30th International Symposium on Intensive Care and Emergency Medicine, Critical Care. Peer-reviewed.
 
Risk factors for hypertriglyceridemia in the intensive care unit: an exploratory study
Devaud Jean-Christophe, Voirol Pierre, Marques-Vidal Pedro Manuel, Tappy Luc, Rodondi Nicolas, Chioléro René, Berger Mette M., Pannatier André, 2010. pp. S197 dans 30th International Symposium on Intensive Care and Emergency Medicine, Brussels, Belgium. 9-12 March 2010, Critical Care. Peer-reviewed.
 
Formation et recherche en pharmacie hospitalière et communautaire – état des lieux et perspectives en Suisse romande
Pannatier André, Bugnon Olivier, Csajka Chantal, Bonnabry Pascal, 2009. Pharmactuel, 42 (Suppl. 1) pp. 53-61. Peer-reviewed.
 
Impact of a computerized physician order entry system on compliance with prescription accuracy requirements.
Mir C., Gadri A., Zelger G.L., Pichon R., Pannatier A., 2009. Pharmacy World and Science, 31 (5) pp. 596-602.
The bioavailability of bromazepam, omeprazole and paracetamol given by nasogastric feeding tube.
Podilsky G., Berger-Gryllaki M., Testa B., Buclin T., Roulet M., Pannatier A., 2009. European Journal of Clinical Pharmacology, 65 (5) pp. 435-442.
 
Cefuroxime prophylaxis is effective in noninstrumented spine surgery: a double-blind, placebo-controlled study.
Petignat C., Francioli P., Harbarth S., Regli L., Porchet F., Reverdin A., Rilliet B., de Tribolet N., Pannatier A., Pittet D. et al., 2008/08. Spine, 33 (18) pp. 1919-1924. Peer-reviewed.
 
Care givers' assessment of the sedation drug use in an adult intensive care unit (ICU) : PT134
Voirol Pierre, Blanc Anne Laure, Delaloye Valia Humbert, Van Tulder Laurence, Gattlen Laurent, Chiolero René, Pannatier André, 2008. p. 730 dans Implementing Clinical Pharmacy in Community and Hospital Settings: Sharing the Experience : ESCP 36th European Symposium on Clinical Pharmacy, Pharmacy World and Science. Peer-reviewed.
 
Suivi de l'adhésion thérapeutique des patients hypertendus ou dyslipi- démiques par les cercles de qualité médecins-pharmaciens [Monitoring drug adherence for hypertensive and dyslipidemic patients in networks of community-based pharmacists and physicians].
Santschi V., Rodondi N., Bugnon O., Pannatier A., Burnier M., 2008. Revue Médicale Suisse, 4 (170) pp. 1928-1936.
 
The development of a stable oral solution of captopril for paediatric patients
Berger-Gryllaki M., Podilsky G., Widmer N., Gloor S., Testa B., Pannatier A., 2007. European Journal of Hospital Pharmacy Science, 13 (3) pp. 67-72. Peer-reviewed.
 
Generiques et article 38a OPAS: quel impact? [Generic drugs and legal incentives: which impact?]
Livio F., Buclin T., Pannatier A., Biollaz J., 2006/04. Revue Médicale Suisse, 2 (61) pp. 966-9.
 
Prescription de medicaments generiques: impact du nouveau systeme de prix sur les couts et les economies potentielles. [Generic drug prescribing: pilot study on the impact of the new drug pricing system on costs and potential savings]
Wasserfallen J. B., Shimia S., Biollaz J., Pannatier A., 2006/03. Revue Médicale Suisse, 2 (59) pp. 865-6, 868-71.
 
Effect of computerisation on the quality and safety of chemotherapy prescription.
Voeffray M., Pannatier A., Stupp R., Fucina N., Leyvraz S., Wasserfallen J.B., 2006. Quality & safety in health care, 15 (6) pp. 418-21.
Unlicensed and off-label drug use in a Swiss paediatric university hospital.
Di Paolo E.R., Stoetter H., Cotting J., Frey P., Gehri M., Beck-Popovic M., Tolsa J.F., Fanconi S., Pannatier A., 2006. Swiss Medical Weekly, 136 (13-14) pp. 218-222. Peer-reviewed.
 
In vitro evaluation of bronchodilator drug delivery by jet nebulization during pediatric mechanical ventilation.
Di Paolo E.R., Pannatier A., Cotting J., 2005/07. Pediatric Critical Care Medicine, 6 (4) pp. 462-469. Peer-reviewed.
 
When fever, paracetamol? Theory and practice in a paediatric outpatient clinic
Gehri M., Guignard E., Djahnine S. R., Cotting J. Q., Yersin C., Di Paolo E. R., Krahenbuhl J. D., Pannatier A., 2005/06. Pharmacy World and Science, 27 (3) pp. 254-7.
 
Formulation optimization in a university hospital - The example of pediatric solutions of the ACE inhibitor captopril.
Berger-Gryllaki M, Podilsky G, Widmer N, Gloor S, Testa B, Pannatier A, 2005. Chimia, 59(6) pp. 357-358. Peer-reviewed.
 
Développement d'une solution orale pédiatrique de captopril
Gryllaki-Berger M., Podilsky G., Widmer N., Gloor S., Pannatier A., 2004. dans 12es Journées Franco-Suisses de Pharmacie Hospitalière.
 
Format of medical order sheet improves security of antibiotics prescription: The experience of an intensive care unit.
Wasserfallen J.B., Bütschi A.J., Muff P., Biollaz J., Schaller M.D., Pannatier A., Revelly J.P., Chiolero R., 2004. Critical Care Medicine, 32 (3) pp. 655-659. Peer-reviewed.
 
Évaluation d'une nouvelle méthode pour l'essai de stérilité des préparations pharmaceutiques
Widmer N., Pannatier A., Blanc D.S., 2003. dans GSASA-Kongress, Gesellschaft schweizerischer Amt- und Spitalapotheker = Congrès annuel de la GSASA, Société suisse des pharmaciens de l'administration et des hôpitaux.
Pharmacological thromboembolic prophylaxis in a medical ward: room for improvement
Aujesky D., Guignard E., Pannatier A., Cornuz J., 2002/10. Journal of General Internal Medicine, 17 (10) pp. 788-91. Peer-reviewed.
 
Transition from unfractionated heparin to low molecular weight heparins
Ghali W. A., Pannatier A., Tsuyuki R. T., Hull R. D., MacKay E., Quan H., Cornuz J., 2002/09. Thrombosis and Haemostasis, 88 (3) pp. 539-40.
 
Efficacy and safety of fluvastatin in hyperlipidemic protease inhibitor-treated HIV-infected patients.
Doser N., Kübli S., Telenti A., Marzolini C., Chave J.P., Feihl F., Buclin T., Pannatier A., Darioli R., Nicod P. et al., 2002. AIDS, 16 (14) pp. 1982-3. Peer-reviewed.
 
Nature et fréquence des associations médicamenteuses susceptibles de majorer la toxicité musculaire des statines [Drug-drug interactions and potential muscle toxicity of statins]
Tissot E., Cornuz J., Darioli R., Mooser V., Pannatier A., 2001. Journal de Pharmacie Clinique, 20 (3) pp. 167-170.
 
Evaluation of physicochemical incompatibilities during parenteral drug administration in a paediatric intensive care unit
Gikic M., Di Paolo E. R., Pannatier A., Cotting J., 2000/06. Pharmacy World and Science, 22 (3) pp. 88-91.
 
Physicochemical aspects of nebulisation: comparison of five models of jet nebulisers
Di Paolo E.R., Cotting J., Pannatier A., 2000. European Hospital Pharmacy, 6 (3) pp. 83-87. Peer-reviewed.
 
Fluconazole prophylaxis prevents intra-abdominal candidiasis in high-risk surgical patients.
Eggimann P., Francioli P., Bille J., Schneider R., Wu M.M., Chapuis G., Chiolero R., Pannatier A., Schilling J., Geroulanos S. et al., 1999. Critical care medicine, 27 (6) pp. 1066-72. Peer-reviewed.
 
Evaluation of nurses' errors associated in the preparation and administration of medication in a pediatric intensive care unit
Schneider M. P., Cotting J., Pannatier A., 1998/08. Pharmacy World and Science, 20 (4) pp. 178-82.
 
A 10-year survey of nutritional support in a surgical ICU: 1986-1995
Berger M. M., Chiolero R. L., Pannatier A., Cayeux M. C., Tappy L., 1997/10. Nutrition, 13 (10) pp. 870-7.
 
Evaluation de l'utilisation des antibiotiques: une etude prospective dans un centre hospitalier universitaire. [Evaluation of antibiotic use: a prospective study in a university hospital center]
Parret T., Schneider R., Rime B., Saghafi L., Pannatier A., Francioli P., 1993/03. Schweizerische Medizinische Wochenschrift, 123 (10) pp. 403-13.
 
A comparative study of formaldehyde detection using chromotropic acid, acetylacetone and HPLC in cosmetics and household cleaning products
Gryllaki-Berger M., Mugny C., Perrenoud D., Pannatier A., Frenk E., 1992/03. Contact Dermatitis, 26 (3) pp. 149-54.
 
Quantitative determination of particulate contamination in intravenous administration sets
Di Paolo E. R., Hirschi B., Pannatier A., 1990/10. Pharmaceutisch Weekblad. Scientific Edition, 12 (5) pp. 190-5.
 
Comparative study between liquid and solid media for the detection of bacterial contamination in intravenous solutions
Pappalardo G., Hirschi B., Pannatier A., Francioli P., 1988/12. Journal of Clinical Pharmacy and Therapeutics, 13 (6) pp. 411-6.
 
Efficacy and stability of two chlorine-containing antiseptics
Pappalardo G., Tanner F., Roussianos D., Pannatier A., 1986. Drugs Under Experimental and Clinical Research, 12 (11) pp. 905-9.
Partagez:
Unicentre - CH-1015 Lausanne
Suisse
Tél. +41 21 692 11 11
Fax. +41 21 692 26 15
Swiss University